Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Faced with the epidemic of opioid addiction, researchers have been charged with finding other strategies to treat pain. Their efforts largely have focused on nerve cells that transmit pain signals to the spinal cord and brain.

6 Jul 2018

Prostate cancer test results may be affected by obesity, shows study

University of Adelaide research shows that the results of the most widely used test for prostate cancer may be affected by obesity.

5 Jul 2018

SATB1 protein important for maintaining pluripotency of hematopoietic stem cells

Osaka University scientists demonstrate that SATB1 is important for maintaining pluripotency of hematopoietic stem cells

4 Jul 2018

Study finds link between testosterone and men's preference for status goods

A recent study conducted by a research team around Hilke Plassmann, the INSEAD Chaired Professor of Decision Neuroscience & Brain and Spine Institute, a principal investigator in the Social Affective Neuroscience Team at the ICM, David Dubois, Associate Professor of Marketing at INSEAD and Gideon Nave, Assistant Professor of Marketing at The Wharton School & the Wharton Neuroscience Initiative shows that testosterone, the male sex hormone, increased men's preference for status goods compared to goods of similar perceived quality but seen as lower in status.

4 Jul 2018

Researchers demonstrate role of oxytocin in cooperative decisions or conversations

The hormone oxytocin has long been known to play a role in the social bonds humans form. For the first time, psychology researcher Jennifer McClung and biology doctoral student Zegni Triki of the Center for Cognitive Science at the University of Neuchâtel demonstrate the role of naturally occurring oxytocin in social interactions, such as cooperative decisions or conversations.

4 Jul 2018

Study does not find causal association between assisted reproduction and ovarian cancer risk

Following concerns over many years that hormonal stimulation of the ovaries necessary for IVF may increase the risk of ovarian cancer, a nationwide cohort study from Denmark has now concluded that any perceived increase in risk is actually a statistical bias resulting from vigilant diagnosis at the time of treatment.

3 Jul 2018

Novel sensing technology enables live and super-sensitive monitoring of biomarkers

The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers.

2 Jul 2018

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.

2 Jul 2018

Hormone lab tests not necessary for most teens with gynecomastia

Routine assessment by an endocrinologist and laboratory tests to measure hormone levels aren't necessary in most adolescent boys with gynecomastia, concludes a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

30 Jun 2018

New guidelines on how to diagnose, treat endocrine disorders in childhood cancer survivors

The Endocrine Society today issued a Clinical Practice Guideline advising healthcare providers on how to diagnose and treat the endocrine disorders that affect a significant portion of childhood cancer survivors in the United States today.

30 Jun 2018

Study: Administration of endocrine disruptor causes epigenetic changes in pregnant sow's DNA

The public debate on endocrine disrupting chemicals- exogenous substances that have the same or similar effects as endogenous hormones - has been going on for some time.

30 Jun 2018

URI researchers working to develop novel medication to treat alcohol use disorder

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year, according to the Centers for Disease Control.

28 Jun 2018

Estrogen may also play a role in migraine for men

While it has been known that estrogen plays a role in migraine for women, new research shows that the female sex hormone may also play a role in migraine for men, according to a small study published in the June 27, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

28 Jun 2018

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic. The findings may provide important information for identifying which patients potentially fare better when treated with an alternate therapy.

26 Jun 2018

Testosterone levels in men largely determined by their childhood environment

Men's testosterone levels are largely determined by their environment during childhood, according to new research.

25 Jun 2018

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for standard review a new supplemental Biologics License Application for KEYTRUDA, Merck's anti-PD-1 therapy, as adjuvant therapy in the treatment of patients with resected, high-risk stage III melanoma and granted a Prescription Drug User Fee Act, or target action, date of February 16, 2019.

25 Jun 2018

Higher BMI at younger age linked to reduced premenopausal breast cancer risk

Having a higher body mass index at a younger age is associated with a decreased risk of developing breast cancer before the menopause, major new research funded by Breast Cancer Now and other collaborators has found.

25 Jun 2018

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

22 Jun 2018

New analysis links higher BMI to lower breast cancer risk for younger women

While obesity has been shown to increase breast cancer risk in postmenopausal women, a large-scale study co-led by a University of North Carolina Lineberger Comprehensive Cancer Center researcher found the opposite is true for premenopausal women: higher body fat was linked to lower breast cancer risk.

21 Jun 2018

Hormone News and Research

Further Reading

Non-opioid drug shows promise for treating pain by targeting receptors on immune cells

Prostate cancer test results may be affected by obesity, shows study

SATB1 protein important for maintaining pluripotency of hematopoietic stem cells

Study finds link between testosterone and men's preference for status goods

Researchers demonstrate role of oxytocin in cooperative decisions or conversations

Study does not find causal association between assisted reproduction and ovarian cancer risk

Novel sensing technology enables live and super-sensitive monitoring of biomarkers

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

New Rekovelle analysis shows AMH is robust predictor of ovarian response to fertility treatment

Hormone lab tests not necessary for most teens with gynecomastia

New guidelines on how to diagnose, treat endocrine disorders in childhood cancer survivors

Study: Administration of endocrine disruptor causes epigenetic changes in pregnant sow's DNA

URI researchers working to develop novel medication to treat alcohol use disorder

Estrogen may also play a role in migraine for men

Study finds byproduct of common prostate cancer drug can stimulate growth of tumor cells

Testosterone levels in men largely determined by their childhood environment

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Higher BMI at younger age linked to reduced premenopausal breast cancer risk

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

New analysis links higher BMI to lower breast cancer risk for younger women

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News